BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 24872453)

  • 21. Characterization of rat liver malonyl-CoA decarboxylase and the study of its role in regulating fatty acid metabolism.
    Dyck JR; Berthiaume LG; Thomas PD; Kantor PF; Barr AJ; Barr R; Singh D; Hopkins TA; Voilley N; Prentki M; Lopaschuk GD
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):599-608. PubMed ID: 10947976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Evolution of the Ribosomal Protein-MDM2-p53 Pathway.
    Deisenroth C; Franklin DA; Zhang Y
    Cold Spring Harb Perspect Med; 2016 Dec; 6(12):. PubMed ID: 27908926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SPIN1 promotes tumorigenesis by blocking the uL18 (universal large ribosomal subunit protein 18)-MDM2-p53 pathway in human cancer.
    Fang Z; Cao B; Liao JM; Deng J; Plummer KD; Liao P; Liu T; Zhang W; Zhang K; Li L; Margolin D; Zeng SX; Xiong J; Lu H
    Elife; 2018 Mar; 7():. PubMed ID: 29547122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of MdmX as a therapeutic target for reactivating p53 in tumors.
    Garcia D; Warr MR; Martins CP; Brown Swigart L; Passegué E; Evan GI
    Genes Dev; 2011 Aug; 25(16):1746-57. PubMed ID: 21852537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress.
    Zhou X; Hao Q; Liao J; Zhang Q; Lu H
    Oncogene; 2013 Jan; 32(3):388-96. PubMed ID: 22391559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ribosomal proteins L11 and L5 activate TAp73 by overcoming MDM2 inhibition.
    Zhou X; Hao Q; Zhang Q; Liao JM; Ke JW; Liao P; Cao B; Lu H
    Cell Death Differ; 2015 May; 22(5):755-66. PubMed ID: 25301064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDM2 binding induces a conformational change in p53 that is opposed by heat-shock protein 90 and precedes p53 proteasomal degradation.
    Sasaki M; Nie L; Maki CG
    J Biol Chem; 2007 May; 282(19):14626-34. PubMed ID: 17363365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical and functional interaction between ribosomal protein L11 and the tumor suppressor ARF.
    Dai MS; Challagundla KB; Sun XX; Palam LR; Zeng SX; Wek RC; Lu H
    J Biol Chem; 2012 May; 287(21):17120-17129. PubMed ID: 22467867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perturbation of RNA Polymerase I transcription machinery by ablation of HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint pathway in human cells.
    Turi Z; Senkyrikova M; Mistrik M; Bartek J; Moudry P
    Cell Cycle; 2018; 17(1):92-101. PubMed ID: 29143558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perturbation of 60 S ribosomal biogenesis results in ribosomal protein L5- and L11-dependent p53 activation.
    Sun XX; Wang YG; Xirodimas DP; Dai MS
    J Biol Chem; 2010 Aug; 285(33):25812-21. PubMed ID: 20554519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromatin-Bound MDM2 Regulates Serine Metabolism and Redox Homeostasis Independently of p53.
    Riscal R; Schrepfer E; Arena G; Cissé MY; Bellvert F; Heuillet M; Rambow F; Bonneil E; Sabourdy F; Vincent C; Ait-Arsa I; Levade T; Thibaut P; Marine JC; Portais JC; Sarry JE; Le Cam L; Linares LK
    Mol Cell; 2016 Jun; 62(6):890-902. PubMed ID: 27264869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation.
    Itahana K; Mao H; Jin A; Itahana Y; Clegg HV; Lindström MS; Bhat KP; Godfrey VL; Evan GI; Zhang Y
    Cancer Cell; 2007 Oct; 12(4):355-66. PubMed ID: 17936560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.
    Lindström MS; Jin A; Deisenroth C; White Wolf G; Zhang Y
    Mol Cell Biol; 2007 Feb; 27(3):1056-68. PubMed ID: 17116689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acrolein preferentially damages nucleolus eliciting ribosomal stress and apoptosis in human cancer cells.
    Wang HT; Chen TY; Weng CW; Yang CH; Tang MS
    Oncotarget; 2016 Dec; 7(49):80450-80464. PubMed ID: 27741518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RP-MDM2-p53 Pathway: Linking Ribosomal Biogenesis and Tumor Surveillance.
    Liu Y; Deisenroth C; Zhang Y
    Trends Cancer; 2016 Apr; 2(4):191-204. PubMed ID: 28741571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of IMP dehydrogenase 2 in Inauhzin-induced ribosomal stress.
    Zhang Q; Zhou X; Wu R; Mosley A; Zeng SX; Xing Z; Lu H
    Elife; 2014 Oct; 3():. PubMed ID: 25347121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ribosomal protein S7 is both a regulator and a substrate of MDM2.
    Zhu Y; Poyurovsky MV; Li Y; Biderman L; Stahl J; Jacq X; Prives C
    Mol Cell; 2009 Aug; 35(3):316-26. PubMed ID: 19683495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations of the Mdm2 C-Terminus Differentially Impact Its Function In Vivo.
    Pant V; Aryal NK; Xiong S; Chau GP; Fowlkes NW; Lozano G
    Cancer Res; 2022 Apr; 82(7):1313-1320. PubMed ID: 35078816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. mTOR inhibitors blunt the p53 response to nucleolar stress by regulating RPL11 and MDM2 levels.
    Goudarzi KM; Nistér M; Lindström MS
    Cancer Biol Ther; 2014; 15(11):1499-514. PubMed ID: 25482947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function.
    Chen D; Zhang Z; Li M; Wang W; Li Y; Rayburn ER; Hill DL; Wang H; Zhang R
    Oncogene; 2007 Aug; 26(35):5029-37. PubMed ID: 17310983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.